Fairbanks Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Fairbanks Capital Management, Inc.

$158 Million
Q3 2024

A detailed history of Fairbanks Capital Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fairbanks Capital Management, Inc. holds 2,393 shares of GILD stock, worth $221,137. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,393

Previous 6,110 60.83%

Holding current value

$221,137

Previous $419,000 52.27%

% of portfolio

0.13%

Previous 0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $247,515 - $312,190	-3,717 Reduced 60.83%	2,393 $200,000
Q1 2024 May 16, 2024	SELL	$71.58 - $87.29 $219,034 - $267,107	-3,060 Reduced 33.37%	6,110 $447,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $90,634 - $102,782	-1,237 Reduced 11.89%	9,170 $742,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $4,066 - $4,436	-55 Reduced 0.53%	10,407 $779,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $119,715 - $136,552	-1,575 Reduced 13.08%	10,462 $806,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $35,562 - $40,516	-460 Reduced 3.68%	12,037 $998,000
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $22,435 - $32,209	-360 Reduced 2.8%	12,497 $1.07 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $97,883 - $111,808	-1,644 Reduced 11.34%	12,857 $793,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $36,883 - $41,541	-639 Reduced 4.22%	14,501 $896,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $59,773 - $74,902	-1,032 Reduced 6.38%	15,140 $900,000
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $661,128 - $713,284	-9,767 Reduced 37.65%	16,172 $1.13 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $177,017 - $193,417	-2,789 Reduced 9.71%	25,939 $1.79 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $5,520 - $6,298	92 Added 0.32%	28,728 $1.86 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $396 - $451	-7 Reduced 0.02%	28,636 $1.67 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $264,732 - $332,855	-4,263 Reduced 12.96%	28,643 $1.81 Million
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $29,948 - $34,776	414 Added 1.27%	32,906 $2.24 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $384,798 - $492,871	-6,144 Reduced 15.9%	32,492 $2.43 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $773,823 - $851,181	-12,558 Reduced 24.53%	38,636 $2.51 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $83,513 - $92,184	-1,336 Reduced 2.54%	51,194 $3.25 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $84,452 - $94,703	-1,365 Reduced 2.53%	52,530 $3.55 Million
Q1 2019 Apr 24, 2019	SELL	$62.53 - $70.05 $9,004 - $10,087	-144 Reduced 0.27%	53,895 $3.5 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $533,236 - $695,832	8,808 Added 19.47%	54,039 $3.38 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $632,681 - $700,493	8,876 Added 24.41%	45,231 $3.49 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $20,826 - $24,293	321 Added 0.89%	36,355 $2.58 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $517,601 - $631,012	-7,106 Reduced 16.47%	36,034 $0
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $106,938 - $125,530	-1,503 Reduced 3.37%	43,140 $3.09 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $3.22 Million - $3.82 Million	44,643	44,643 $3.62 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairbanks Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fairbanks Capital Management, Inc. with notifications on news.

Account

Fairbanks Capital Management, Inc. Gilead Sciences, Inc. Transaction History